Droxidopa is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sciegen Pharmaceuticals Inc. The primary component is Droxidopa.
Product ID | 50228-431_bbb2d8e3-70b5-78f2-e053-2995a90a285e |
NDC | 50228-431 |
Product Type | Human Prescription Drug |
Proprietary Name | Droxidopa |
Generic Name | Droxidopa |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2021-02-18 |
Marketing Category | ANDA / |
Application Number | ANDA214017 |
Labeler Name | ScieGen Pharmaceuticals Inc |
Substance Name | DROXIDOPA |
Active Ingredient Strength | 300 mg/1 |
Pharm Classes | Catecholamines [CS],Increased Blood Pressure [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-02-18 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0054-0532 | Droxidopa | Droxidopa |
0054-0533 | Droxidopa | Droxidopa |
0054-0534 | Droxidopa | Droxidopa |
0832-0720 | Droxidopa | Droxidopa |
0832-0721 | Droxidopa | Droxidopa |
0832-0722 | Droxidopa | Droxidopa |
27241-199 | Droxidopa | Droxidopa |
27241-200 | Droxidopa | Droxidopa |
27241-201 | Droxidopa | Droxidopa |
27808-199 | droxidopa | droxidopa |
27808-200 | droxidopa | droxidopa |
27808-201 | droxidopa | droxidopa |
31722-010 | Droxidopa | Droxidopa |
31722-014 | Droxidopa | Droxidopa |
31722-015 | Droxidopa | Droxidopa |
50228-429 | Droxidopa | droxidopa |
50228-430 | Droxidopa | droxidopa |
50228-431 | Droxidopa | droxidopa |
59651-375 | Droxidopa | Droxidopa |
59651-376 | Droxidopa | Droxidopa |
59651-377 | Droxidopa | Droxidopa |
63304-086 | droxidopa | droxidopa |
63304-104 | droxidopa | droxidopa |
63304-112 | droxidopa | droxidopa |
67386-820 | Northera | droxidopa |
67386-821 | Northera | droxidopa |
67386-822 | Northera | droxidopa |